Avascular necrosis as a manifestation of post-COVID syndrome in routine practice of rheumatologist

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Avascular necrosis as a part of post-COVID syndrome requires increased attention of physicians due to significant misfunction of musculoskeletal system, increased disability, and frequently requires surgical intervention. It is known that hypercoagulation, thrombosis as well as systemic corticosteroid therapy during severe coronavirus infection play an important role in the development of avascular necrosis. A case report of progressive avascular necrosis in multiple loci accompanied by polyarthritis in a young man developed after severe COVID-19 is reported below.

Sobre autores

I. Bazina

Smolensk State Medical University

Autor responsável pela correspondência
Email: billy_boss@mail.ru

Candidate of Medical Sciences

Rússia, Smolensk

D. Krechikova

Clinical hospital «RZhD-Medicine»

Email: billy_boss@mail.ru

Candidate of Medical Sciences

Rússia, Smolensk

O. Kozyrev

Smolensk State Medical University

Email: billy_boss@mail.ru

Doctor of Medical Sciences, Professor

Rússia, Smolensk

M. Pavlova

Smolensk State Medical University

Email: billy_boss@mail.ru
Rússia, Smolensk

I. Loginova

Smolensk State Medical University

Email: billy_boss@mail.ru
Rússia, Smolensk

V. Kononova

Smolensk State Medical University

Email: billy_boss@mail.ru
Rússia, Smolensk

L. Yakub

Smolensk State Medical University

Email: billy_boss@mail.ru
Rússia, Smolensk

Bibliografia

  1. Насонов Е.Л., Лила А.М., Мазуров В.И. и др. Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной организации «Ассоциация ревматологов России». Научно-практическая ревматология. 2021; 59 (3): 239–54 [Nasonov E.L., Lila A.M., Mazurov V.I. et al. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia. Rheumatology Science and Practice. 2021; 59 (3): 239–54 (in Russ.)]. doi: 10.47360/1995-4484-2021-239-254
  2. Lopez-Leon S., Wegman-Ostrosky T., Perelman C. et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv. 2021; 2021.01.27.21250617 (Preprint). doi: 10.1101/2021.01.27.21250617
  3. Fan B.E., Umapathi T., Chua K. et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis. 2021; 51 (4): 971–7. doi: 10.1007/s11239-020-02332-z
  4. Zhang W., Zhao Y., Zhang F. et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020; 214: 108393. doi: 10.1016/j.clim.2020.108393
  5. Zhang Y., Xiao M., Zhang S. et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020; 382 (17): e38. doi: 10.1056/NEJMc2007575
  6. Karaarslan F., Güneri F.D., Kardeş S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022; 41 (1): 289–96. doi: 10.1007/s10067-021-05942-x
  7. Насонов Е.Л., Бекетова Т.В., Решетняк Т.М. и др. Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания: на перекрестке проблем тромбовоспаления и аутоиммунитета. Научно-практическая ревматология. 2020; 58 (4): 353–67 [Nasonov E.L., Beketova T.V., Reshetnyak T.M. et al. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity. Rheumatology Science and Practice. 2020; 58 (4): 353–67 (in Russ.)]. doi: 10.47360/1995-4484-2020-353-367
  8. Zuo Y., Zuo M., Yalavarthi S. et al. Neutrophil extracellular traps and thrombosis in COVID-19. medRxiv. 2020; 2020.04.30.20086736 (Preprint). doi: 10.1101/2020.04.30.20086736
  9. Chan K.L., Mok C.C. Glucocorticoid-induced avascular bone necrosis: Diagnosis and management. Open Orthop J. 2012; 6: 449–57. doi: 10.2174/1874325001206010449
  10. Drescher W., Schlieper G., Floege J. et al. Steroid-related osteonecrosis – an update. Nephrol Dial Transplant. 2011; 26 (9): 2728–31. doi: 10.1093/ndt/gfr212
  11. Assouline-Dayan Y., Chang C., Greenspan A. et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002; 32 (2): 94–124.
  12. Xie L., Liu Y., Fan B. et al. Dynamic changes of serum SARS-Coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res. 2005; 6 (1): 5. doi: 10.1186/1465-9921-6-5
  13. D Orth S.A., Vijayvargiya M. A paradigm shift in osteonecrosis treatment with bisphosphonates: A 20-year study. JB JS Open Access. 2021; 6 (4): e21.00042. doi: 10.2106/JBJS.OA.21.00042
  14. Horikawa A., Miyakoshi N., Hongo M. et al. Treatment of spontaneous osteonecrosis of the knee by daily teriparatide: A report of 3 cases. Medicine (Baltimore). 2020; 99 (5): e18989. doi: 10.1097/MD.0000000000018989

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2. Fig. 1. No active focal and infiltrative shadows are found in the lungs; the roots are structural, the diaphragm is usually located, with even contours; the sinuses are free; the aorta has no characteristics

Baixar (59KB)
Metadados
3. Fig. 2. The right joint space is sharply narrowed; the right femoral head is deformed and has a heterogeneous structure

Baixar (46KB)
Metadados

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).